我是 LongbridgeAI，我可以总结文章信息。医疗保健股票在主要制药公司发布混合财报后下跌。辉瑞的股票因癌症和心脏病药物销售强劲，抵消了 COVID-19 产品的下滑，尽管超出了盈利目标，股价上涨。默克的股票略微上涨，因为它因 Terns Pharmaceuticals 收购的单次费用下调了年度利润预测。相反，尽管诺和诺德提高了年度收入预测，其股票仍然下滑
Health-care companies ticked down after mixed earnings from Big Pharma companies. Investors rotated out of defensive areas into cyclical stocks.
Pfizer shares rose after the New York drug giant posted second-quarter earnings above Wall Street targets, as rising sales of drugs for cancer and heart disease helped offset steep declines for Covid-19 products.
Merck slashed its profit projection for the year, citing one-off charges tied to its acquisition of cancer biotech company Terns Pharmaceuticals. Shares of Merck rose slightly.
Shares of Danish obesity-drug maker Novo Nordisk slid despite raising its revenue projection for the year.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
August 04, 2026 18:12 ET (22:12 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.